AACR Cancer Experts Forecast Research and Treatment Advances for 2023
PHILADELPHIA – Cancer Research Catalyst, the official blog of the American Association for Cancer Research (AACR), started the new year with a post titled “Experts Forecast Cancer Research and Treatment Advances in 2023.”
In the post, five eminent AACR experts share their thoughts on significant developments in cancer research in the coming year:
- Philip D. Greenberg, MD, FAACR, AACR President-Elect and editor-in-chief of the AACR journal Cancer Immunology Research, discusses the future of cancer immunotherapy;
- Lillian Siu, MD, editor-in-chief of the AACR’s newest journal, Cancer Research Communications, covers areas of exciting progress in precision medicine;
- Timothy Rebbeck, PhD, member of the AACR Cancer Prevention Working Group Steering Committee, shares his thoughts on what’s next in cancer prevention and early detection;
- Anna Barker, PhD, FAACR, chair of the AACR Scientist↔Survivor Program, discusses the main themes that will shape the landscape of patient advocacy in the coming year; and
- Melissa B. Davis, PhD, member of the AACR Minorities in Cancer Research Council, provides insight into the future of cancer disparities research.
Journalists are welcome to use the blog post and its graphics and videos. Please cite the American Association for Cancer Research and link back to the post.
This post is part of the continuing mission of Cancer Research Catalyst to further accelerate the growth and spread of knowledge about cancer, while providing helpful and interesting information to AACR members and the public.
Visit the blog and subscribe.